Sino Biological,Inc. (SHE:301047)
65.70
+2.00 (3.14%)
At close: Jun 2, 2026
Sino Biological,Inc. Market Cap
Sino Biological,Inc. has a market cap or net worth of 7.99 billion as of June 2, 2026. Its market cap has increased by 8.72% in one year.
Market Cap
7.99B
Enterprise Value
4.78B
Revenue
727.69M
Ranking
n/a
PE Ratio
50.82
Stock Price
65.70
Market Cap Chart
Since August 16, 2021, Sino Biological,Inc.'s market cap has decreased from 33.55B to 7.99B, a decrease of -76.18%. That is a compound annual growth rate of -25.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 7.75B | -5.77% |
| Dec 31, 2025 | 8.22B | 9.30% |
| Dec 31, 2024 | 7.52B | -29.33% |
| Dec 29, 2023 | 10.65B | -17.32% |
| Dec 30, 2022 | 12.88B | -45.23% |
| Dec 31, 2021 | 23.51B | -29.92% |
| Aug 16, 2021 | 33.55B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 8.32B |
| Jiangxi Fushine Pharmaceutical | 8.24B |
| Aurisco Pharmaceutical | 8.00B |
| Bio-Thera Solutions | 7.94B |
| GemPharmatech | 7.93B |
| Youcare Pharmaceutical Group | 7.92B |
| Zhejiang Ausun Pharmaceutical | 7.85B |
| Shanghai Medicilon | 7.85B |